Home Spirometry in Cystic Fibrosis: Accuracy and Responsiveness
Author Information
Author(s): Coristine Andrew, Heidenreich Julius Frederik, Wucherpfennig L, Donaldson Scott H, Oppelaar Martinus C, van Helvoort Hanneke AC, Bannier Michiel AGE, Reijers Monique HE, van der Vaart Hester, van der Meer Renske, Altenburg Josje, Conemans Lennart, Rottier Bart L, Nuijsink Marianne, van den Wijngaart Lara S, Merkus Peter JFM, Roukema Jolt
Primary Institution: Radboud University Medical Center
Hypothesis
This study aimed to assess the accuracy, reproducibility, and responsiveness to treatment of home spirometry in long-term pediatric and adult cystic fibrosis care.
Conclusion
Home spirometry is feasible but not equal to clinic spirometry, and it can confirm whether lung functions remain stable.
Supporting Evidence
- Home spirometry outcomes were significantly lower than clinic spirometry.
- 87.3% of FEV1 measurements met reproducibility criteria.
- Median percentage change in FEV1 after starting treatment was 19.2%.
Takeaway
This study shows that using spirometers at home can help people with cystic fibrosis check their lung health, but the results might not be as good as those from a doctor's office.
Methodology
A retrospective observational study was conducted in 5 Dutch cystic fibrosis centers, collecting home spirometry outcomes for 601 users over 3 years.
Potential Biases
Potential selection bias due to the anonymous nature of the data and the lack of supervision during home spirometry.
Limitations
The use of anonymous data limited the ability to track pulmonary exacerbations or therapy use, and some age data was missing.
Participant Demographics
Median age was 26 years, with 51% male and 44% female participants.
Statistical Information
P-Value
p<0.01
Confidence Interval
95% CI 0.10 to 0.19 for FEV1; 95% CI 0.14 to 0.25 for FVC
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website